Quick Answer
Pelthos Therapeutics Inc. reported Cash and Equivalents of $17.97 million for fiscal year 2025.
Pelthos Therapeutics Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $17.97M | +3403.5% |
| 2024 | $513.0K | — |
- Pelthos Therapeutics Inc. showed an increase of +3403.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2024–2025 period, Pelthos Therapeutics Inc.’s cash and equivalents has grown by 3403.5% (from $513.0 thousand to $17.97 million).
- The most recent figure is from Pelthos Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: